Moderna highlights expanding mRNA platform at Science Day

▤ Summary

Moderna used its Science Day to showcase the expansion of its mRNA platform across infectious disease, cancer, and rare disease programs. The company highlighted a multi-horizon strategy that spans approved products, clinical-stage assets, and future modalities under development. It also pointed to ongoing use of data, AI, machine learning, and robotics to accelerate discovery and development. The update reinforces Moderna’s push to scale its pipeline while advancing new candidates toward clinical milestones.

▦ Linked Companies